Which country is the originator drug of Valganciclovir produced in and its manufacturer information?

Valganciclovir (Valganciclovir) is an oral antiviral drug mainly used to treat and prevent human cytomegalovirus (CMV) infection. As an oral prodrug, it can be rapidly converted into ganciclovir in the body and exerts antiviral effects by inhibiting viral DNA polymerase. Vancevir is widely used for the treatment of organ transplants, high-risk immunosuppressed patients, and CMV-related eye or gastrointestinal infections.

The original drug Vancevir is developed and produced by Gilead Sciences, Inc. in the United States. Gilead Sciences is a biopharmaceutical company headquartered in California, USA, known for its research and development of antiviral drugs, covering HIV, hepatitis and other viral diseases. Vancevir is Gilead's important product in the anti-CMV drug series and one of its important antiviral drugs in the global market.

Vancevi is marketed and sold in many countries and regions around the world, and drug quality and production strictly follow the approval standards of the U.S. Food and Drug Administration (FDA). During the production process, Gilead adopts high-standard pharmaceutical processes and quality control systems to ensure drug stability, purity and effectiveness. In addition, the original drug has sufficient clinical data, and its efficacy and safety have been rigorously verified, providing reliable basis for clinical use.
In the Chinese market, the original drug of Vancevir has been officially launched and has become an important choice for the treatment of CMV infection. When prescribing, doctors can select the dose based on the patient's liver and kidney function, severity of illness, and previous medication history, and develop an individualized treatment plan based on hematology and virology monitoring. Since the original drug has a clear manufacturer and quality assurance, patients can obtain stable efficacy and good safety when using it, and at the same time enjoy the protection of regular drug purchase channels.
Reference: https://www.drugs.com/